Elite receives FDA OK for generic VyvanseGeneric Vyvanse is indicated for the treatment of Attention Deficit Hyperactivity Disorder. Alembic receives FDA nod for generic CorlanorIvabradine is indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction. Camber releases generic Xeloda Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers. Hims & Hers Health plans to launch generic of Novo Nordisk's Victoza Liraglutide, used to treat Type 2 diabetes, belongs to the first generation of GLP-1 agonists. FDA gives Lupin tentative nod for generic Isentress Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus infection. Alembic obtains FDA nod for generic Cardizem Generic Cardizem is indicated for the treatment of hypertension and the management of chronic stable angina and angina due to coronary artery spasm. Sandoz launches generic paclitaxel in single-dose vial The single-dose 100 mg vial for intravenous use is approved for metastatic breast cancer. Alembic releases generic Arranon Nelarabine injection is indicated for the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Formosa, DÁVI ink deal for clobetasol propionate ophthalmic suspension Clobetasol propionate ophthalmic suspension is used to treat inflammation and pain following ocular surgery. Upsher-Smith intros generic Zyprexa Olanzapine tablets had a market value of roughly $46 million for the 12 months ending August 2024, per IQVIA. First Previous 1 2 3 4 5 Next Last
